Search Results

The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors

The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors

Pharmacology Series: Updates in Guidelines for Chronic Conditions: “Diabetes”

Pharmacology Series: Updates in Guidelines for Chronic Conditions: “Diabetes”

Nephroprotection 2025: "4 Pillars" & EASi-KIDNEY - Dr. Doreen Zhu & Dr. Parminder Judge (Oxford, UK)

Nephroprotection 2025: "4 Pillars" & EASi-KIDNEY - Dr. Doreen Zhu & Dr. Parminder Judge (Oxford, UK)

First Metformin + SGLT2i + DPP4i FDC in India | Dr Sambit Das | NUCD 2022

First Metformin + SGLT2i + DPP4i FDC in India | Dr Sambit Das | NUCD 2022

What causes diabetes? The 13 different reasons by Jothydev

What causes diabetes? The 13 different reasons by Jothydev

Uncover the Secrets of Top 200 Drugs: Flashcards Edition

Uncover the Secrets of Top 200 Drugs: Flashcards Edition

Prevention & management strategies of HTN IN DM.Prof Dr Jahanzaib BMC Quetta

Prevention & management strategies of HTN IN DM.Prof Dr Jahanzaib BMC Quetta

[TCTAP 2021 Virtual] Plenary Session of TCTAP 2021 - Part-I: Coronary and Antithrombotics

[TCTAP 2021 Virtual] Plenary Session of TCTAP 2021 - Part-I: Coronary and Antithrombotics

3D 2018 | Session 7 | DR M SHANMUGAVELU

3D 2018 | Session 7 | DR M SHANMUGAVELU

Prevention of Diabetes Mellitus and Management of Pre Diabetes and Metabolic Syndrome

Prevention of Diabetes Mellitus and Management of Pre Diabetes and Metabolic Syndrome

P. Kalyvas | Diabetes in HFpEF: Comorbidity or causative factor?

P. Kalyvas | Diabetes in HFpEF: Comorbidity or causative factor?

FFPAI ENDOCRINE UPDATE SERIES

FFPAI ENDOCRINE UPDATE SERIES